News About: Pharm. Industry


Recent SARS fear batters drug exports

The domestic pharmaceutical industry raised a serious concern about the drug export to China critically hampered by the outbreak of SARS mainly due to remarkable declined drug consumption in China and the logistic dif...

Marketing strategies to segment by seasonal diseases.

The pharmaceutical companies are pushing their marketing promotional campaigns over the items for the seasonal market demand, such as yellow dusts blown from the China desert, SARS and allergenic pollens. The indus...

Pharmaceutical trade balance swings positive

Korea's pharmaceutical trade imbalance has been markedly improved for three straight months this year, as the on-year growth rate of pharmaceutical exports exceed that of imports by two times, according to sta...

Industry to strengthen OTC drug sales and public advertising.

The domestic pharmaceutical industry tried to achieve this year ambitious sales target by strengthening the OTC new product development. Their forecasted sales targets last year were achieved merely by 80 to 90% of...

Products for children's stature growth on hot competition.

A lot of nutritional supplement food products for the children's stature growth are now in market with severe competition, starting "Long Keybon" developed by Chongkundang in 1999 formulated with some herbal drugs, th...

KPMA to reject the lowest actual transaction pricing system.

The KPMA admitted with a whopping backlash that the NHI drug price slashes applying the post management system for the lowest actual transaction drug price ultimately caused the pharmaceutical industry to collapse. ...

Government urged to promote R&D new drug projects

Current estimates put the average research and development cost in Korea of a wholly new drug in the range of 10.6 billion won with the relevant period of 8.9 years, according to the list revealed by the Korea...

Local drug makers brace for severe damage

Korea's drug makers are bracing for a prolonged downdraft in the domestic pharmaceutical market following the government's ex post facto drug pricing inspection on 4,300 items from 190 medical institutions, which have...

Domestic antihypertensive market heavily contested

Witnessing more than 20 percent in sales growth year-on-year, the domestic antihypertensive market in 2002 was estimated to be about 600 million won with 170 items and expanded by 43 percent as of the end of last year...

Multinational drug firms post brisk sales

Foreign drug manufacturers in the local market have been on the receiving end of a sales bonanza since medical reforms were instituted three years ago, whereas Korean drug manufacturers are on edge. Rep. Ki...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.